DNLI 8-K 2026-06-18

Denali Therapeutics Inc. (DNLI) 8-K dated 2026-06-18 — accession 0001714899-26-000081. This URL is the filing, not the DNLI hub.

Denali Therapeutics Inc. (DNLI) is a biotechnology company listed on US.

Denali Therapeutics Inc. filed a 8-K on 2026-06-18. Accession 0001714899-26-000081.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.

Not investment advice. The DNLI SEC hub lists recent forms. The stock page is the research view.